LENSAR, Inc.

LNSR Healthcare Medical Devices

LENSAR, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $58.4 million, up 9.24% from fiscal 2024. In the quarter to June 2026, revenue grew 18.4%, EPS grew 291.7% and free cash flow grew 96.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

5.80 0.23 −3.81%
Market cap
$74.1M
P/E
2.0×
Fwd P/E
7.1×
Dividend yield
—
F-score
3/9
Altman Z
−2.84
Beneish M
−4.30
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 5 4 4 5 3 3
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 2.53 2.53 1.27 1.63 0.78 1.05 1.92 2.38
Altman Z-Score
— — — 0.98 1.47 (1.22) (0.99) (1.26) (2.84)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— (4.33) (4.79) 6.10 2.74 (2.32) (2.17) (5.37) (10.13)
P/Operating CF
— (1,221.55) (1,221.55) (16.78) (75.98) (5.83) (92.34) 28.16 225.03
Beneish M-Score
— — (2.95) (3.34) (2.17) (2.80) (2.94) (4.13) (4.30)
P/B ratio
— 0.97 0.97 0.50 1.02 0.66 1.33 21.18 0.00
Price to Tangible BV
— 1.19 1.19 0.61 1.28 0.93 1.98 0.00 0.00
EV/Sales
— 1.16 1.16 (0.03) 0.89 0.55 0.63 1.62 2.18
EV/EBITDA
— 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
— (1.66) (1.66) 0.06 (3.44) (1.30) (2.75) (38.17) (8.59)
EV/FCF
— (1.63) (1.63) 0.06 (3.31) (1.29) (2.69) (35.72) (8.54)
Quick Ratio
— 0.87 1.02 5.03 4.16 1.81 2.41 1.90 0.60
Current Ratio
— 1.53 2.19 6.90 5.14 2.95 3.99 2.80 1.15
Net Debt/EBITDA
— (0.63) (1.76) 2.55 1.87 0.88 2.76 3.22 0.89
Debt/Assets
0.00% 21.88% 58.49% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
— (0.31) (0.66) 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
— 1.69 0.96 0.46 0.47 0.58 0.67 0.79 0.85
Operating CF/Net income
— 0.13 0.86 0.70 0.46 0.75 0.67 0.07 0.43
Capex/Depreciation
— (0.71) (0.54) (0.13) (0.13) (0.03) (0.07) (0.04) (0.02)
Interest Coverage
— (2.81) (6.35) (13.81) — (1,186.88) — — —
ROE
— 55.06% 57.46% (107.89%) (32.11%) (41.12%) (38.14%) (164.03%) 324.05%
ROA
— (97.24%) (46.22%) (34.80%) (26.93%) (32.56%) (22.93%) (46.22%) (49.78%)
ROIC
— 0.00% 0.00% (43.45%) (52.85%) (46.18%) (81.61%) 0.00% 0.00%
Return on Tangible Assets
— (293.44%) (145.49%) (38.96%) (53.18%) (87.12%) (40.53%) (113.62%) (511.49%)
Average Days of Receivables
— 49.42 40.46 27.84 49.13 62.35 34.64 41.52 39.83
Research and Development Expense of Revenue
— 11.42% 24.79% 28.63% 35.86% 33.41% 14.56% 9.96% 9.62%
Selling, General and Administrative Expense of Revenue
— 66.19% 56.17% 90.09% 69.32% 76.84% 61.90% 49.52% 77.28%
Intangible Assets out of Total Assets
0.00 0.43 0.39 0.15 0.16 0.22 0.16 0.09 0.07
Share Based Compensation of Revenue
— 0.50% 0.33% 34.28% 19.93% 18.70% 13.14% 4.98% 5.38%
Graham Net Nets
— 0.72 0.72 1.39 0.59 0.72 0.23 (0.19) (0.36)
Graham Number
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.92
Earnings Yield
— (94.64%) (94.64%) (125.07%) (34.89%) (72.16%) (32.89%) (30.43%) (24.94%)
Free Cash Flow Yield
— (28.07%) (28.07%) (42.14%) (16.60%) (53.98%) (22.32%) (2.36%) (10.72%)
Revenue per Share
— 22.79 28.53 5.71 3.68 3.48 3.84 4.64 4.89
Operating CF per Share
— (1.76) (11.77) (2.98) (0.96) (1.46) (0.88) (0.20) (1.24)
Capex per Share
— (3.04) (1.95) (0.07) (0.04) (0.01) (0.02) (0.01) (0.01)
Free Cash Flow per Share
— (4.80) (13.72) (3.05) (0.99) (1.47) (0.90) (0.21) (1.25)
Cash per Share
— 3.13 4.31 8.79 3.38 1.44 2.19 1.95 1.50
Shareholders Equity per Share
— (19.13) (28.55) 14.54 5.85 4.13 3.05 0.42 (2.18)
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— (19.13) (28.55) 14.54 5.85 4.13 3.05 0.42 (2.18)
Free Cash Flow
— (5.13) (14.68) (14.12) (9.32) (14.97) (9.89) (2.43) (14.91)
Working Capital
— 4.09 9.35 49.92 36.10 22.30 34.81 26.98 6.20
Capital Expenditures
— (3.25) (2.09) (0.33) (0.35) (0.11) (0.24) (0.16) (0.08)
Net Current Asset Value
— (37.60) (47.91) 46.48 33.23 19.86 10.29 (19.46) (50.68)
EV/EBIT
— 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.00
Capex to Sales
— 0.13 0.07 0.01 0.01 0.00 0.01 0.00 0.00
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— 6.57 5.37 3.08 3.66 6.05 5.16 5.54 8.56
Cash ROIC
— 47.53% 255.80% (13.09%) (10.78%) (26.42%) (17.21%) (8.90%) 185.47%
Accounts Receivable Turnover
— 6.37 9.13 9.78 10.36 6.62 8.40 10.61 9.38
Accounts Payable Turnover
— 9.13 11.58 6.07 6.43 3.80 4.47 5.53 2.51
Inventory Turnover
— 2.25 2.85 1.14 1.67 1.69 1.54 2.04 1.90
Average Days of Payables
— 37.78 33.27 73.58 59.14 128.48 69.46 79.16 221.26
Days of Inventory on Hand
— 108.70 170.15 399.58 142.43 278.20 271.95 150.90 250.85
Average Receivables
— 3.83 3.34 2.70 3.33 5.34 5.02 5.04 6.23
Average Payables
— 1.49 1.49 2.03 2.59 4.06 4.71 5.00 12.49
Average Inventory
— 6.06 6.06 10.77 9.98 9.11 13.71 13.56 16.47
Average Assets
— 14.44 31.71 56.83 72.79 61.15 62.71 67.94 68.86
Average Common Equity
— (25.51) (25.51) 18.33 61.04 48.43 37.71 19.15 (10.58)

Fold the line items

Columns are period end dates